The Designation Economy
What hospital designations cost, earn, and risk — a market assessment built entirely from public sources: peer-reviewed studies, published fee schedules, federal purchase orders, and CMS records. Adversarially verified, dated dollars disclosed, negative findings kept — and why the same evidence file that satisfies a surveyor is the one the AI cases now in discovery demand. Below are the highlights; the full paper is the PDF.
~6,100 hospitals hold a designation. No one holds the portfolio.
Stroke certification alone is split across four certifying bodies — and state governments certify more stroke centers than the Joint Commission. No single accreditor’s tooling can cover a hospital’s whole designation portfolio.
| Designation | Count | Source |
|---|---|---|
| Stroke centers (any designation) | ~2,446 of 5,533 US EDs — TJC 1,371 · state gov 1,427 · DNV 191 · HFAP 60 (certifier counts include dual-certified centers) | PMC8886184 (2022) |
| Trauma centers (all levels) | ~2,302 — L I 253 · II 314 · III 493 · IV 923 · V 111 | Definitive Healthcare, Dec 2025 |
| Commission on Cancer programs | ~1,400 | facs.org |
| Baby-Friendly facilities | 600+ · >28% of US births | babyfriendlyusa.org |
Readiness already costs seven figures. Proof costs five.
Quote-only, single-certifier, mid-six-figures per cycle.
No readiness vendor publishes a list price — so we mined real obligated federal dollars from USAspending.gov. The stack a hospital assembles runs mid-six-figures per survey cycle, none of it cross-certifier. Price opacity is a category property; a published five-figure price is a differentiator.
| Product / service | Real paid price | Buyer, period |
|---|---|---|
| Survey-tracking cockpit (enterprise license) | ~$234K / yr | DoD Navy, 2017–2021 |
| Accreditor “continuous readiness” program | $9.71M / ~6 yrs | VA, 2010–2016 |
| Readiness consulting engagement | $177K–$285K | VA, 2008–2015 |
| Mock survey (single site → network-wide) | $25K–$151K | VA/DoD, 2009–2011 |
| Policy tool (small facility → area-wide) | $12K–$62K / yr | IHS, 2020–2027 |
The biggest accreditation overhaul since 1965 lands this year — and the AI cases reach discovery in the same one.
Accreditation 360 forces every accredited hospital’s quality office to re-map its compliance infrastructure in 2026 — incumbent tooling must be reconfigured anyway, so switching costs are at their historic minimum. And certification for responsible AI use launched June 1, 2026, covering five areas — open to facilities regardless of which accreditor surveys them.
The legal clock runs faster than the accreditation one. Payer-algorithm suits are already in discovery: Lokken v. UnitedHealth drew a March 2026 order on the nH Predict model, and Kisting-Leung v. Cigna kept its ERISA claims against a review averaging 1.2 seconds per file. A second wave has reached the delivery side — Saucedo v. Sharp (Nov 2025), the first AI-scribe class action against a health system, over 100,000+ encounters; Washington v. Sutter Health / MemorialCare (Apr 2026), pleading CIPA at $5,000 per interception; Winters v. OpenAI (Jul 2026), the first missed-diagnosis claim against an AI agent; and the Texas Attorney General’s Sept 2024 settlement with Pieces Technologies over hallucination rates the vendor could not substantiate. Every theory ends in the same demand: produce the record. In Lisota v. Heartland (dismissed Jan 2026), the documented operating posture was the defense.
We show our work — including what we couldn’t prove.
Method & Honest Disclosures
- Three research passes, the first adversarially vote-verified: every surviving claim withstood independent attempts to refute it. Confidence labels ride with every figure in the PDF.
- Dated dollars are disclosed, not inflation-adjusted: the mock-survey purchase orders are 2009–2011; service-line revenue studies are ~2015–2018.
- Negative findings are kept: no incumbent publishes a list price; no public purchase order exists for several major consultancies; no 2015+ study isolates the revenue lost from losing a designation — CMS termination cases are the honest loss anchor.
- A designation is a patient-safety instrument, not only a revenue one: the public outcome evidence is real and honestly associational — an estimated 1.9 million neurons lost per untreated minute in a large-vessel stroke (a modeled figure; Saver, Stroke 2006); 21% higher adjusted odds of in-hospital death for injured patients whose drive time rose after a trauma-center closure (associated with, not caused by; Hsia et al., J Trauma Acute Care Surg 2014); more preterm births after remote rural obstetric-unit closures (+0.67 pp; Kozhimannil et al., JAMA 2018). We present these as adjusted-association stakes, not causal claims.
- Litigation is cited as filed, not as decided: the AI matters named in section 4 are public court filings with outcomes pending — Kisting-Leung survived a motion to dismiss, it did not prevail. The $556M Kaiser settlement is a chart-review False Claims Act matter, not an AI case, and we do not count it as one. Nothing here is legal advice.
- What’s still open is listed in the PDF: quality-department budget lines, the current ACS-verified national total, and non-federal paid prices remain unpublished — we say so rather than estimate silently.
Every source is named: peer-reviewed studies by PubMed/PMC id, fee schedules by certifier, purchase orders by award, regulations by CFR section. If you can’t trace a number in the PDF to its source, tell us and we’ll fix the paper.
Read the whole assessment.
All six sections with every source, confidence label, and open question — then see the same numbers run against your own designation portfolio in the digital pilot.
PDF · no email gate · every claim traceable to a public source.